Investing.com - Pieris Pharmaceuticals Inc reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Pieris Pharmaceuticals Inc announced earnings per share of $-0.130 on revenue of $5.37M. Analysts polled by Investing.com anticipated EPS of $-0.105 on revenue of $10.47M.
Pieris Pharmaceuticals Inc shares are down 25.34% from the beginning of the year and are trading at $1.020 , down-from-52-week-high.
Pieris Pharmaceuticals Inc follows other major Healthcare sector earnings this month
Pieris Pharmaceuticals Inc's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar